Tissue and circulating proprotein convertase subtilisin/Kexin type 9 (PCSK9) as promising prognostic biomarkers for curative-intent colorectal liver metastases resection: A case-control study
{{output}}
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of cholesterol metabolism homeostasis. However, its significance in colorectal cancer liver metastasis (CRLM) remains undetermined. Here, we eva... ...
